SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001390777-19-000099
Filing Date
2019-09-10
Accepted
2019-09-10 15:27:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 TherapeuticsMD_13G_Filing.txt SC 13G/A 49781
  Complete submission text file 0001390777-19-000099.txt   51677
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Subject) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-32384 | Film No.: 191085204
SIC: 2834 Pharmaceutical Preparations

Mailing Address 240 GREENWICH STREET NEW YORK NY 10286
Business Address 240 GREENWICH STREET NEW YORK NY 10286 212-495-1784
Bank of New York Mellon Corp (Filed by) CIK: 0001390777 (see all company filings)

IRS No.: 132614959 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6022 State Commercial Banks